Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.

Advanced drug delivery reviews - 7 Dec 2002

Small Gary W

Abstract excerpt

The neuropathological and cognitive changes preceding Alzheimer's disease appear to begin subtly decades before symptoms of the disease make the clinical diagnosis obvious. Clinical trials have begun to focus on preventive treatments designed to slow age-related cognitive decline and delay the on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoprotein E4
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to APOE gene

Share to Genetic Predisposition to Disease

Share to Tomography, Emission-Computed

Source

Identifiers

PMID: 12453673
DOI: 10.1016/s0169-409x(02)00151-5

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-12453673-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.PMID 12453673Read ↗

Brain-imaging surrogate markers for detection and prevention of age-related memory loss.Semantic proximity Read ↗

Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.Semantic proximity Read ↗

APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.Semantic proximity Read ↗

Characterizing the Preclinical Stages of Alzheimer's Disease and the Prospect of Presymptomatic InterventionSemantic proximity Read ↗

Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's diseaseSemantic proximity Read ↗

Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.Semantic proximity Read ↗

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.Semantic proximity Read ↗

Early detection of Alzheimer's disease using neuroimaging.Semantic proximity Read ↗

A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.Semantic proximity Read ↗

Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer NetworkSemantic proximity Read ↗

Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.Semantic proximity Read ↗

Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.